Motherboard

Major Global Medical Device Manufacturer OrbusNeich Medical Group Announces Details of Proposed Listing on the Main Board of HKEX

Retrieved on: 
Tuesday, December 13, 2022

HONG KONG, Dec 13, 2022 - (ACN Newswire) - OrbusNeich Medical Group Holdings Limited ("OrbusNeich" or the "Group"), a major global medical device manufacturer specialized in interventional instruments for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures, has today announced the details of its proposed listing on the Main Board of The Stock Exchange of Hong Kong Limited ("HKEX").

Key Points: 
  • HONG KONG, Dec 13, 2022 - (ACN Newswire) - OrbusNeich Medical Group Holdings Limited ("OrbusNeich" or the "Group"), a major global medical device manufacturer specialized in interventional instruments for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures, has today announced the details of its proposed listing on the Main Board of The Stock Exchange of Hong Kong Limited ("HKEX").
  • In 2021, its global sales volume of PCI balloon products reached approximately 866,000 units
    -- A major PTA balloon developer and manufacturer in the global PTA balloons market, ranked No.
  • Dealing of the shares is expected to commence on the Main Board of HKEX on 23 December 2022 (Friday) under the stock code 6929.
  • OrbusNeich, headquartered in Hong Kong Science Park, is a major global medical device manufacturer specialized in interventional instruments for PCI and PTA procedures.

Melco Announces Further Details of Gaming Concession

Retrieved on: 
Sunday, December 18, 2022

The Macau SAR government has allocated 750 gaming tables and 2,100 electronic gaming machines for operation by the Concessionaire during the Concession.

Key Points: 
  • The Macau SAR government has allocated 750 gaming tables and 2,100 electronic gaming machines for operation by the Concessionaire during the Concession.
  • Under the Concession, Melco Resorts Macau will pay an annual premium to the Macau SAR of MOP30,000,000 (equivalent to approximately US$3,741,000) plus a variable amount calculated in accordance with the number of gaming tables and electronic gaming machines operated by Melco Resorts Macau.
  • The Concession provides for the payment of special gaming tax on gross gaming revenue.
  • The Company enthusiastically welcomes the grant of the Concession to Melco Resorts Macau, which will enable Melco Resorts Macau to continue its core gaming and entertainment business in the Macau SAR for the next decade.

GHY and Curtin University Sign MOU to Jointly Shape the Next Generation of Media & Film Talents in the Region

Retrieved on: 
Thursday, December 8, 2022

Ltd., a subsidiary of GHY, has signed a non-binding memorandum of understanding ("MOU") with a world-renowned education establishment, Curtin University, for an academic collaboration in higher education programs in Asia related to media and film studies.

Key Points: 
  • Ltd., a subsidiary of GHY, has signed a non-binding memorandum of understanding ("MOU") with a world-renowned education establishment, Curtin University, for an academic collaboration in higher education programs in Asia related to media and film studies.
  • Curtin University is an innovative, global university known for its high-impact research, strong industry partnerships and commitment to preparing students for jobs of the future.
  • Curtin University is one of the top universities worldwide and it has campuses in Western Australia, Singapore, Malaysia, Dubai and Mauritius.
  • Since its establishment, GHY has placed a strong emphasis on identifying, nurturing and promoting talent in the media and film industry across Southeast Asia.

KANZHUN LIMITED Announces Proposed Dual Primary Listing on The Stock Exchange of Hong Kong Limited

Retrieved on: 
Friday, December 16, 2022

The Company has received a letter of in-principle approval to the listing application from the HKEX on December 15, 2022 (Beijing/Hong Kong Time) for the dual primary listing of the Shares on the Main Board of the HKEX.

Key Points: 
  • The Company has received a letter of in-principle approval to the listing application from the HKEX on December 15, 2022 (Beijing/Hong Kong Time) for the dual primary listing of the Shares on the Main Board of the HKEX.
  • The listing document relating to the proposed dual primary listing of the Shares by way of introduction on the Main Board of the HKEX (the “Listing Document”) has been published on the website of the HKEX on December 16, 2022 (Beijing/Hong Kong Time).
  • With respect to the proposed dual primary listing on the Main Board of the HKEX, Morgan Stanley Asia Limited and Goldman Sachs (Asia) L.L.C.
  • Please refer to the section headed “Market Arrangements to Facilitate Dealings in Hong Kong” of the Listing Document for further details.

GTJAI Was Awarded as the Best Companies to Work for in Asia 2022 by HR Asia

Retrieved on: 
Thursday, December 1, 2022

Guotai Junan International Holdings Limited ("Guotai Junan International", the "Company" or "GTJAI", Stock Code: 1788.HK) announced that the Company was delighted to be awarded by HR Asia, a professional human resources publication, as the Best Companies to Work For In Asia 2022 - HONG KONG Region.

Key Points: 
  • Guotai Junan International Holdings Limited ("Guotai Junan International", the "Company" or "GTJAI", Stock Code: 1788.HK) announced that the Company was delighted to be awarded by HR Asia, a professional human resources publication, as the Best Companies to Work For In Asia 2022 - HONG KONG Region.
  • GTJAI was also invited to attend the announcement ceremony held on Wednesday, November 30.
  • To GTJAI, the award has demonstrated the recognition of the Company's high level of corporate governance and human resource management achievements from the market and industry.
  • View the full release here: https://www.businesswire.com/news/home/20221130006208/en/
    Ms. Qi Haiying, Chief Executive Officer and Executive Director of GTJAI, said that the Company was honored to be awarded as The Best Companies to Work for in Asia.

AEON Credit Secures its Framework for Sustainability-Linked Loans, Strengthens and Advances its Sustainability Pledge

Retrieved on: 
Wednesday, November 30, 2022

The Loans are the Group's first sustainable financing initiative and strengthens its commitment to endorsing and developing in the sustainability arena.

Key Points: 
  • The Loans are the Group's first sustainable financing initiative and strengthens its commitment to endorsing and developing in the sustainability arena.
  • Sustainability performance metrics have been set in accordance with AEON Credit's existing Sustainability Development Policy, and will be assessed on an annual basis by the external reviewer, the Hong Kong Quality Assurance Agency.
  • Mr. Tomoharu Fukayama, Managing Director of AEON Credit, said, "We are delighted to have arranged the Group's sustainability-linked loan framework for bank financing, which emphasizes our long-term commitment to the advancement of sustainable development.
  • Looking ahead, we will continue to proactively seek further opportunities to expand our sustainable financing portfolio and look forward to taking our stakeholders along on our sustainability journey."

NovaBay Pharmaceuticals Announces the Launch of DERMAdoctor’s TikTok Store in China and Expands Online Marketing in the U.S. and China

Retrieved on: 
Tuesday, November 29, 2022

We recently ran a successful campaign in China during the 12 days of Double 11, so named because it ends on November 11th.

Key Points: 
  • We recently ran a successful campaign in China during the 12 days of Double 11, so named because it ends on November 11th.
  • Earlier this year, we engaged Doumai, a leading e-commerce solution provider, to refresh our DERMAdoctor e-commerce store on TMall, the Chinese counterpart to Amazon in China.
  • Im pleased to say that our online store has gained 15,000 followers, with more than 30,000 consumers so far placing DERMAdoctor product orders through Tmall.
  • NovaBay Pharmaceuticals, Inc. is a pharmaceutical company that develops and sells scientifically created and clinically proven eyecare and skincare products.

Innovent Announced Clinical Data of Multiple Trials Will be Presented at the 2022 ESMO-IO and ASH Annual Meetings

Retrieved on: 
Monday, November 28, 2022

On October 31, 2018, Innovent was listed on the Main Board of the Stock Exchange of Hong Kong Limited with the stock code: 01801.HK.

Key Points: 
  • On October 31, 2018, Innovent was listed on the Main Board of the Stock Exchange of Hong Kong Limited with the stock code: 01801.HK.
  • Since its inception, Innovent has developed a fully integrated multi-functional platform which includes R&D, CMC (Chemistry, Manufacturing, and Controls), clinical development and commercialization capabilities.
  • An additional 2 assets are under NMPA NDA review, 5 assets are in Phase 3 or pivotal clinical trials, and 20 more molecules are in clinical studies.
  • Innovent has built an international team with advanced talent in high-end biological drug development and commercialization, including many global experts.

Chow Tai Fook Jewellery Group announces Chief People Officer

Retrieved on: 
Sunday, November 27, 2022

(Hong Kong, China, 21 November 2022) Chow Tai Fook Jewellery Group Limited ("Chow Tai Fook Jewellery Group", the "Group" or the "Company"; SEHK stock code: 1929), a Hong Kong Main Board listed company, is delighted to announce the appointment of Ms. Theresa Lui as Chief People Officer on 28 November 2022.

Key Points: 
  • (Hong Kong, China, 21 November 2022) Chow Tai Fook Jewellery Group Limited ("Chow Tai Fook Jewellery Group", the "Group" or the "Company"; SEHK stock code: 1929), a Hong Kong Main Board listed company, is delighted to announce the appointment of Ms. Theresa Lui as Chief People Officer on 28 November 2022.
  • As Chief People Officer, Theresa will spearhead the strategic direction of Chow Tai Fook Jewellerys HR function to ensure optimum people strategies are in place to support the long-term development of the Group.
  • Ms. Sonia Cheng, Vice-Chairman of Chow Tai Fook Jewellery Group remarked, As we look to strengthen Chow Tai Fook Jewellerys team, our focus on people remains laser focused.
  • Chow Tai Fook Jewellery Group Limited (the Group; SEHK stock code: 1929) was listed on the Main Board of The Stock Exchange of Hong Kong in December 2011.

Chow Tai Fook Jewellery Group Announces FY2023 Interim Results

Retrieved on: 
Sunday, November 27, 2022

The Board has declared an interim dividend of HK$0.22 per share in 1HFY2023, representing a payout ratio of approximately 66.0% (1HFY2022: 61.4%).

Key Points: 
  • The Board has declared an interim dividend of HK$0.22 per share in 1HFY2023, representing a payout ratio of approximately 66.0% (1HFY2022: 61.4%).
  • Dr. Henry Cheng, Chow Tai Fook Jewellery Group Chairman, said: As the world continues to evolve in rapid and unpredictable ways, Chow Tai Fook has demonstrated its resilience in managing risks while seeking new opportunities.
  • The Groups retail network expanded to 6,948 POS as at 30 September 2022, with a net addition of 933 CHOW TAI FOOK JEWELLERY POS in the Mainland during the period.
  • Chow Tai Fook Jewellery Group Limited (the Group; SEHK stock code: 1929) was listed on the Main Board of The Stock Exchange of Hong Kong in December 2011.